Real-life adherence to subcutaneous immunotherapy: What has changed in the era of the COVID-19 pandemic

BACKGROUND: Allergen immunotherapy (AIT) must be continued for 3 years, to achieve a long-term modifying effect. Adherence is a key to ensure effectiveness. The objective of this study was, first of all, to evaluate the adherence with subcutaneous immunotherapy (SCIT) and to identify the main causes...

Descripción completa

Detalles Bibliográficos
Autores principales: Koca Kalkan, Ilkay, Ates, Hale, Aksu, Kurtulus, Yesilkaya, Selma, Topel, Musa, Cuhadar Ercelebi, Dilek, Turkyilmaz, Suleyman, Oncul, Ali, Demir, Senay
Formato: Online Artículo Texto
Lenguaje:English
Publicado: World Allergy Organization 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8185179/
https://www.ncbi.nlm.nih.gov/pubmed/34122718
http://dx.doi.org/10.1016/j.waojou.2021.100558

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8185179/
https://www.ncbi.nlm.nih.gov/pubmed/34122718
http://dx.doi.org/10.1016/j.waojou.2021.100558

Ejemplares similares